Finnish
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
Maedica 2019-Dec

Alcohol and Psychoactive Drugs in Pregnancy.

Vain rekisteröityneet käyttäjät voivat kääntää artikkeleita
Kirjaudu sisään Rekisteröidy
Linkki tallennetaan leikepöydälle
Andreea Hetea
Cristiana Cosconel
Ana Stanescu
Anca Simionescu

Avainsanat

Abstrakti

Although often difficult to diagnose, the use of psychoactive drugs during pregnancy has become a commonly encountered occurrence. The present article aims to clarify the effects of alcohol, tobacco, narcotics, antidepressants, stimulants, halucinogenes and canabioids consumption on pregnancy and the newborn. There are differences within the types of drugs consumption: use/abuse/addiction of psychoactive medication during pregnancy. The fetal alcohol syndrome occurs in case of alcohol exposure during pregnancy. It is characterized by fetal alcohol spectrum disorders, lower neurobehavioral scores, mental retardation, heart defects and special facial features. Heroin consumption can lead to prematurity, intrauterine growth restriction, stillbirth or to hemorrhage in the third trimester of pregnancy; it can be associated with malnutrition, venereal diseases, hepatitis, pulmonary complications or preeclampsia. During pregnancy, the effects of cocaine use include cardiovascular complications, neurological complications, infections (sexually transmitted diseases - gonorrhea, Chlamydia infections, syphilis, HPV), obstetric complications (premature birth, fetal death, abruptio placentae). In the fetus, the consequences of cocaine consumption can trigger limb defects, urinary tract malformations, fetal microcephaly, perinatal cerebral infarctions. In conclusion, identifying the profile of pregnant drug users can trigger better care both for the mother, and for the fetus; information and prevention campaigns should provide data on their adverse effects on pregnancy.

Liity facebook-sivullemme

Täydellisin lääketieteellinen tietokanta tieteen tukemana

  • Toimii 55 kielellä
  • Yrttilääkkeet tieteen tukemana
  • Yrttien tunnistaminen kuvan perusteella
  • Interaktiivinen GPS-kartta - merkitse yrtit sijaintiin (tulossa pian)
  • Lue hakuusi liittyviä tieteellisiä julkaisuja
  • Hae lääkekasveja niiden vaikutusten perusteella
  • Järjestä kiinnostuksesi ja pysy ajan tasalla uutisista, kliinisistä tutkimuksista ja patenteista

Kirjoita oire tai sairaus ja lue yrtteistä, jotka saattavat auttaa, kirjoita yrtti ja näe taudit ja oireet, joita vastaan sitä käytetään.
* Kaikki tiedot perustuvat julkaistuun tieteelliseen tutkimukseen

Google Play badgeApp Store badge